Proteases of Parasitic Protozoa - Current Status and Validation

Antiparasitic and Antibacterial Drug Discovery: From Molecular Targets to Drug Candidates

Volumn , Issue , 2009, Pages 175-209

  Sajid, Mohammed ^a,b   Blackman, Michael J ^c   Doyle, Patricia ^a   He, Chen ^d   Land, Kirkwood M ^e   Lobo, Cheryl ^f   Mackey, Zachary ^a   Ndao, Momar ^g   Reed, Sharon L ^d   Shiels, Brian ^h   Swenerton, Ryan ^a   Weir, William ^h  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^d UCSD MEDICAL CENTER   (United States)

^e UNIVERSITY OF THE PACIFIC   (United States)

^f NEW YORK BLOOD CENTER   (United States)

^g MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^h UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Chemotherapy; Drug target; Parasite protease; Parasitic protozoa; Target validation

Indexed keywords

EID: 84891035282     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527626816.ch11     Document Type: Chapter

References (163)

1. Francis, S.E., Gluzman, I.Y., Oksman, A., Knickerbocker, A., Mueller, R., Bryant, M.L., Sherman, A. et al. (1994) Molecular characterization and inhibition of a Plasmodium falciparum aspartic hemoglobinase. The EMBO Journal, 13, 306-317.
2. Banerjee, R., Liu, J., Beatty, W., Pelosof, L., Klemba, M. and Goldberg, D.E. (2002) Four plasmepsins are active in the Plasmodium falciparum food vacuole, including a protease with an active-site histidine. Proceedings of the National Academy of Sciences of the United States of America, 99, 990-995.
3. Shenai, B.R., Lee, B.J., Alvarez-Hernandez, A., Chong, P.Y., Emal, C.D., Neitz, R.J., Roush, W.R. and Rosenthal, P.J. (2003) Structure-activity relationships for inhibition ofcysteine protease activity and development of Plasmodium falciparum by peptidyl vinyl sulfones. Antimicrobial Agents and Chemotherapy, 47, 154-160.
4. Sijwali, P.S., Shenai, B.R., Gut, J., Singh, A. and Rosenthal, P.J. (2001) Expression and characterization of the Plasmodium falciparum haemoglobinase falcipain-3. The Biochemical Journal, 360, 481-489.
5. Singh, N., Sijwali, P.S., Pandey, K.C. and Rosenthal, P.J. (2006) Plasmodium falciparum: biochemical characterization of the cysteine protease falcipain-2'. Experimental Parasitology, 112, 187-192.
6. Eggleson, K.K., Duffin, K.L. and Goldberg, D.E. (1999) Identification and characterization of falcilysin, a metallopeptidase involved in hemoglobin catabolism within the malaria parasite Plasmodium falciparum. The Journal of Biological Chemistry, 274, 32411-32417.
7. Murata, C.E. and Goldberg, D.E. (2003) Plasmodium falciparum falcilysin: a metalloprotease with dual specificity. The Journal of Biological Chemistry, 278, 38022-38028.
8. Florent, I., Derhy, Z., Allary, M., Monsigny, M., Mayer, R. and Schrevel, J. (1998) A Plasmodium falciparum aminopeptidase gene belonging to the M1 family of zinc-metallopeptidases is expressed in erythrocytic stages. Molecular and Biochemical Parasitology, 97, 149-160.
9. Nankya-Kitaka, M.F., Curley, G.P., Gavigan, C.S., Bell, A. and Dalton, J.P. (1998) Plasmodium chabaudi chabaudi and P. falciparum: inhibition of aminopeptidase and parasite growth by bestatin and nitrobestatin. Parasitology Research, 84, 552-558.
10. Gavigan, C.S., Dalton, J.P. and Bell, A. (2001) The role of aminopeptidases in haemoglobin degradation in Plasmodium falciparum-infected erythrocytes. Molecular and Biochemical Parasitology, 117, 37-48.
11. Allary, M., Schrevel, J. and Florent, I. (2002) Properties, stage-dependent expression and localization of Plasmodium falciparum M1 family zinc-aminopeptidase. Parasitology, 125, 1-10.
12. Gardiner, D.L., Trenholme, K.R., SkinnerAdams, T.S., Stack, C.M. and Dalton, J.P. (2006) Overexpression of leucyl aminopeptidase in Plasmodium falciparum parasites. Target for the anti-malarial activity ofbestatin. The Journal of Biological Chemistry, 281, 1741-1745.
13. Dalal, S. and Klemba, M. (2007) Roles for two aminopeptidases in vacuolar hemoglobin catabolism in Plasmodium falciparum. The Journal of Biological Chemistry, 282, 35978-35987.
14. Drew, M.E., Banerjee, R., Uffman, E.W., Gilbertson, S., Rosenthal, P.J. and Goldberg, D.E. (2008) Plasmodium food vacuole plasmepsins are activated by falcipains. The Journal of Biological Chemistry, 283, 12870-12876.
15. Ponpuak, M., Klemba, M., Park, M., Gluzman, I.Y., Lamppa, G.K. and Goldberg, D.E. (2007) A role for falcilysin in transit peptide degradation in the Plasmodium falciparum apicoplast. Molecular Microbiology, 63, 314-334.
16. Ralph, S.A. (2007) Subcellular multitasking-multiple destinations and roles for the Plasmodium falcilysin protease. Molecular Microbiology, 63, 309-313.
17. Eksi, S., Czesny, B., van Gemert, G.J., Sauerwein, R.W., Eling, W. and Williamson, K.C. (2007) Inhibition of Plasmodium falciparum oocyst production by membrane-permeant cysteine protease inhibitor E64d. Antimicrobial Agents and Chemotherapy, 51, 1064-1070.
18. Klemba, M., Gluzman, I. and Goldberg, D.E. (2004) A Plasmodium falciparum dipeptidyl aminopeptidase I participates in vacuolar hemoglobin degradation. The Journal of Biological Chemistry, 279, 43000-43007.
19. Aly, A.S. and Matuschewski, K. (2005) A malarial cysteine protease is necessaryfor Plasmodium sporozoite egress from oocysts. The Journal of Experimental Medicine, 202, 225-230.
20. Miller, S.K., Good, R.T., Drew, D.R., Delorenzi, M., Sanders, P.R., Hodder, A.N., Speed, T.P. et al. (2002) A subset of Plasmodium falciparum SERA genes are expressed and appear to play an important role in the erythrocytic cycle. The Journal of Biological Chemistry, 277, 47524-47532.
21. McCoubrie, J.E., Miller, S.K., Sargeant, T., Good, R.T., Hodder, A.N., Speed, T.P., de Koning-Ward, T.F. and Crabb, B.S. (2007) Evidence for a common role for the serine-type Plasmodium falciparum SERA proteases: Implications for vaccine and drug design. Infection and Immunity, 75, 5565-5574.
22. Yeoh, S., O'Donnell, R.A., Koussis, K., Dluzewski, A.R., Ansell, K.H., Osborne, S.A., Hackett, F. et al. (2007) Subcellular discharge of a serine protease mediates release of invasive malaria parasites from host erythrocytes. Cell, 131, 1072-1083.
23. Blackman, M.J. (2000) Proteases involved in erythrocyte invasion by the malaria parasite: function and potential as chemotherapeutic targets. Current Drug Targets, 1, 59-83.
24. Barale, J.C., Blisnick, T., Fujioka, H., Alzari, P.M., Aikawa, M., Braun-Breton, C. and Langsley, G. (1999) Plasmodium falciparum subtilisin-like protease 2, a merozoite candidate for the merozoite surface protein 1-42 maturase. Proceedings of the National Academy of Sciences of the United States of America, 96, 6445-6450.
25. Hackett, F., Sajid, M., Withers-Martinez, C., Grainger, M. and Blackman, M.J. (1999) PfSUB-2: a second subtilisin-like protein in Plasmodium falciparum merozoites. Molecular and Biochemical Parasitology, 103, 183-195.
26. Harris, P.K., Yeoh, S., Dluzewski, A.R., O'Donnell, R.A., Withers-Martinez, C., Hackett, F., Bannister, L.H. et al. (2005) Molecular identification of a malaria merozoite surface sheddase. PLoS Pathogens, 1, 241-251.
27. Howell, S.A., Well, I., Fleck, S.L., Kettleborough, C., Collins, C.R. and Blackman, M.J. (2003) A single malaria merozoite serine protease mediates shedding of multiple surface proteins by juxtamembrane cleavage. The Journal of Biological Chemistry, 278, 23890-23898.
28. Green, J.L., Hinds, L., Grainger, M., Knuepfer, E. and Holder, A.A. (2006) Plasmodium thrombospondin related apical merozoite protein (PTRAMP) is shed from the surface of merozoites by PfSUB2 upon invasion of erythrocytes. Molecular and Biochemical Parasitology, 150, 114-117.
29. Baker, R.P., Wijetilaka, R. and Urban, S. (2006) Two Plasmodium rhomboid proteases preferentially cleave different adhesins implicated in all invasive stages of malaria. PLoS Pathogens, 2, e113.
30. O'Donnell, R.A., Hackett, F., Howell, S.A., Treeck, M., Struck, N., Krnajski, Z., Withers-Martinez, C. et al. (2006) Intramembrane proteolysis mediates shedding of a key adhesin during erythrocyte invasion by the malaria parasite. The Journal of Cell Biology, 174, 1023-1033.
31. Coppi, A., Pinzon-Ortiz, C., Hutter, C. and Sinnis, P. (2005) The Plasmodium circumsporozoite protein is proteolytically processed during cell invasion. The Journal of Experimental Medicine, 201, 27-33.
32. Coppi, A., Tewari, R., Bishop, J.R., Bennett, B.L., Lawrence, R., Esko, J.D., Billker, O. and Sinnis, P. (2007) Heparan sulfate proteoglycans provide a signal to Plasmodium sporozoites to stop migrating and productively invade host cells. Cell Host Microbe, 2, 316-327.
33. Sturm, A., Amino, R., van de Sand, C., Regen, T., Retzlaff, S., Rennenberg, A., Krueger, A. et al. (2006) Manipulation of host hepatocytes by the malaria parasite for delivery into liver sinusoids. Science, 313, 1287-1290.
34. Sturm, A. and Heussler, V. (2007) Live and let die: manipulation of host hepatocytes by exoerythrocytic Plasmodium parasites. Medical Microbiology and Immunology, 196, 127-133.
35. Hodder, A.N., Drew, D.R., Epa, V.C., Delorenzi, M., Bourgon, R., Miller, S.K., Moritz, R.L. et al. (2003) Enzymic, phylogenetic, and structural characterization of the unusual papain-like protease domain of Plasmodium falciparum SERA5. The Journal of Biological Chemistry, 278, 48169-48177.
36. Chagas, C. (1981) Carlos Chagas: Coletanea De Traalhos Cientificos, 6, Editora Universidad de Brasilia, pp. 247-258.
37. Parada, H., Carrasco, H.A., Anez, N., Fuenmayor, C. and Inglessis, I. (1997) Cardiac involvement is a constant finding in acute Chagas' disease: a clinical, parasitological and histopathological study. International Journal of Cardiology, 60, 49-54.
38. Ferreira, M.S. (1999) Chagas' disease and immunosuppression. Memorias do Institute Oswaldo Cruz, 94 (Supp. 1), 325-327.
39. CDC (2002) Chagas' disease after organ transplantation. United States. Morbidity and Mortality Weekly Report, 51, 210-212.
40. Chimelli, L. and Scaravilli, F. (1997) Trypanosomiasis. Brain Pathology (Zurich, Switzerland), 7, 599-611.
41. Engel, J.C., Doyle, P.S., Hsieh, I. and McKerrow, J.H. (1998) Cysteine protease inhibitors cure an experimental Trypanosoma cruzi infection. The Journal of Experimental Medicine, 188, 725-734.
42. Engel, J.C., Doyle, P.S., Palmer, J., Hsieh, I., Bainton, D.F. and McKerrow, J.H. (1998) Cysteine protease inhibitors alter Golgi complex ultrastructure and function in Trypanosoma cruzi. Journal of Cell Science, 111 (Pt 5), 597-606.
43. Souto-Padron, T., Campetella, O.E., Cazzulo, J.J. and de Souza, W. (1990) Cysteine proteinase in Trypanosoma cruzi: immunocytochemical localization and involvement in parasite-host cell interaction. Journal of Cell Science, 96 (Pt 3), 485-490.
44. Soares, M.J., Souto-Padron, T. and De Souza, W. (1992) Identification of a large pre-lysosomal compartment in the pathogenic protozoon Trypanosoma cruzi. Journal of Cell Science, 102 (Pt 1), 157-167.
45. Bontempi, E., Martinez, J. and Cazzulo, J.J. (1989) Subcellular localization of a cysteine proteinase from Trypanosoma cruzi. Molecular and Biochemical Parasitology, 33, 43-47.
46. Labriola, C., Cazzulo, J.J. and Parodi, A.J. (1995) Retention of glucose units added by the UDP-GLC:glycoprotein glucosyltransferase delays exit of glycoproteins from the endoplasmic reticulum. The Journal of Cell Biology, 130, 771-779.
47. Doyle, P.S., Sajid, M., O'Brien, T., DuBois, K., Engel, J.C., Mackey, Z.B. and Reed, S. (2008) Drugs targeting parasite lysosomes. Current Pharmaceutical Design, 14, 889-900.
48. Wendel, K.A. and Workowski, K.A. (2007) Trichomoniasis: challenges to appropriate management. Clinical Infectious Diseases, 44 (Supp. 3), S123-S129.
49. Min, D.Y., Hyun, K.H., Ryu, J.S., Ahn, M.H. and Cho, M.H. (1998) Degradations of human immunoglobulins and hemoglobin by a 60 kDa cysteine proteinase of Trichomonas vaginalis. The Korean Journal of Parasitology, 36, 261-268.
50. Mallinson, D.J., Lockwood, B.C., Coombs, G.H. and North, M.J. (1994) Identification and molecular cloning of four cysteine proteinase genes from the pathogenic protozoon Trichomonas vaginalis. Microbiology (Reading, England), 140 (Pt 10), 2725-2735.
51. Alvarez-Sanchez, M.E., Avila-Gonzalez, L., Becerril-Garcia, C., Fattel-Facenda, L.V., Ortega-Lopez, J. and Arroyo, R. (2000) A novel cysteine proteinase (CP65) of Trichomonas vaginalis involved in cytotoxicity. Microbial Pathogenesis, 28, 193-202.
52. Irvine, J.W., North, M.J. and Coombs, G.H. (1997) Use of inhibitors to identify essential cysteine proteinases of Trichomonas vaginalis. FEMS Microbiology Letters, 149, 45-50.
53. Sommer, U., Costello, C.E., Hayes, G.R., Beach, D.H., Gilbert, R.O., Lucas, J.J. and Singh, B.N. (2005) Identification of Trichomonas vaginalis cysteine proteases that induce apoptosis in human vaginal epithelial cells. The Journal of Biological Chemistry, 280, 23853-23860.
54. Leon-Felix, J., Ortega-Lopez, J., Orozco-Solis, R. and Arroyo, R. (2004) Two novel asparaginyl endopeptidase-like cysteine proteinases from the protist Trichomonas vaginalis: their evolutionary relationship within the clan CD cysteine proteinases. Gene, 335, 25-35.
55. Spielman, A. (1985) Ecology of Ixodes dammini-borne human babesiosis and Lyme disease. Annual Review of Entomology, 30, 439-460.
56. Lantos, P.M. and Krause, P.J. (2002) Babesiosis: similar to malaria but different. Pediatric Annals, 31, 192-197.
57. Ruebush, T.K. 2nd, Juranek, D.D., Chisholm, E.S., Snow, P.C., Healy, G.R. and Sulzer, A.J. (1977) Human babesiosis on Nantucket Island. Evidence for self-limited and subclinical infections. The New England Journal of Medicine, 297, 825-827.
58. Montero, E., Rafiq, S., Heck, S. and Lobo, C.A. (2007) Inhibition of human erythrocyte invasion by Babesia divergens using serine protease inhibitors. Molecular and Biochemical Parasitology, 153, 80-84.
59. Okubo, K., Yokoyama, N., Govind, Y., Alhassan, A. and Igarashi, I. (2007) Babesia bovis: effects of cysteine protease inhibitors on in vitro growth. Experimental Parasitology, 117, 214-217.
60. Greenbaum, D., Baruch, A., Hayrapetian, L., Darula, Z., Burlingame, A., Medzihradszky, K.F. and Bogyo, M. (2002) Chemical approaches for functionally probing the proteome. Molecular & Cellular Proteomics, 1, 60-68.
61. Liu, Y., Patricelli, M.P. and Cravatt, B.F. (1999) Activity-based protein profiling: the serine hydrolases. Proceedings of the National Academy of Sciences of the United States of America, 96, 14694-14699.
62. Montero, E., Gonzalez, L.M., Rodriguez, M., Oksov, Y., Blackman, M.J. and Lobo, C.A. (2006) A conserved subtilisin protease identified in Babesia divergens merozoites. The Journal of Biological Chemistry, 281, 35717-35726.
63. Stanley, S.L. Jr (2003) Amoebiasis. Lancet, 361, 1025-1034.
64. Reed, S.L., Keene, W.E. and McKerrow, J.H. (1989) Thiol proteinase expression and pathogenicity of Entamoeba histolytica. Journal of Clinical Microbiology, 27, 2772-2777.
65. Keene, W.E., Petitt, M.G., Allen, S. and McKerrow, J.H. (1986) The major neutral proteinase of Entamoeba histolytica. The Journal of Experimental Medicine, 163, 536-549.
66. Reed, S.L. and Gigli, I. (1990) Lysis of complement-sensitive Entamoeba histolytica by activated terminal complement components. Initiation of complement activation by an extracellular neutral cysteine proteinase. The Journal of Clinical Investigation, 86, 1815-1822.
67. Kelsall, B.L. and Ravdin, J.I. (1993) Degradation of human IgA by Entamoeba histolytica. The Journal of Infectious Diseases, 168, 1319-1322.
68. Tran, V.Q., Herdman, D.S., Torian, B.E. and Reed, S.L. (1998) The neutral cysteine proteinase of Entamoeba histolytica degrades IgG and prevents its binding. The Journal of Infectious Diseases, 177, 508-511.
69. Reed, S.L. (1995) New concepts regarding the pathogenesis of amebiasis. Clinical Infectious Diseases, 21 (Supp. 2), S182-S185.
70. Que, X., Kim, S.H., Sajid, M., Eckmann, L., Dinarello, C.A., McKerrow, J.H. and Reed, S.L. (2003) A surface amebic cysteine proteinase inactivates interleukin-18. Infection and Immunity, 71, 1274-1280.
71. Scott, D.A., North, M.J. and Coombs, G.H. (1995) The pathway of secretion of proteinases in Trichomonas vaginalis. International Journal for Parasitology, 25, 657-666.
72. Clark, C.G., Alsmark, U.C., Tazreiter, M., Saito-Nakano, Y., Ali, V., Marion, S., Weber, C. et al. (2007) Structure and content of the Entamoeba histolytica genome. Advances in Parasitology-Opportunistic Protozoa in Humans, 65, 51-190.
73. Que, X., Brinen, L.S., Perkins, P., Herdman, S., Hirata, K., Torian, B.E., Rubin, H. et al. (2002) Cysteine proteinases from distinct cellular compartments are recruited to phagocytic vesicles by Entamoeba histolytica. Molecular and Biochemical Parasitology, 119, 23-32.
74. Bruchhaus, I., Loftus, B.J., Hall, N. and Tannich, E. (2003) The intestinal protozoan parasite Entamoeba histolytica contains 20 cysteine protease genes, of which only a small subset is expressed during in vitro cultivation. Eukaryotic Cell, 2, 501-509.
75. Tillack, M., Biller, L., Irmer, H., Freitas, M., Gomes, M.A., Tannich, E. and Bruchhaus, I. (2007) The Entamoeba histolyticagenome: primary structure and expression of proteolytic enzymes. BMC Genomics, 8, 170.
76. Gilchrist, C.A., Houpt, E., Trapaidze, N., Fei, Z., Crasta, O., Asgharpour, A., Evans, C. et al. (2006) Impact of intestinal colonization and invasion on the Entamoeba histolytica transcriptome. Molecular and Biochemical Parasitology, 147, 163-176.
77. Melendez-Lopez, S.G., Herdman, S., Hirata, K., Choi, M.H., Choe, Y., Craik, C., Caffrey, C.R. et al. (2007) Use of recombinant Entamoeba histolytica cysteine proteinase 1 to identify a potent inhibitor of amebic invasion in a human colonic model. Eukaryotic Cell, 6, 1130-1136.
78. Hellberg, A., Nowak, N., Leippe, M., Tannich, E. and Bruchhaus, I. (2002) Recombinant expression and purification of an enzymatically active cysteine proteinase of the protozoan parasite Entamoeba histolytica. Protein Expression and Purification, 24, 131-137.
79. Moncada, D., Keller, K., Ankri, S., Mirelman, D. and Chadee, K. (2006) Antisense inhibition of Entamoeba histolytica cysteine proteases inhibits colonic mucus degradation. Gastroenterology, 130, 721-730.
80. Keene, W.E., Hidalgo, M.E., Orozco, E. and McKerrow, J.H. (1990) Entamoeba histolytica: correlation of the cytopathic effect of virulent trophozoites with secretion of a cysteine proteinase. Experimental Parasitology, 71, 199-206.
81. Stanley, S.L. Jr, Zhang, T., Rubin, D. and Li, E. (1995) Role of the Entamoeba histolytica cysteine proteinase in amebic liver abscess formation in severe combined immunodeficient mice. Infection and Immunity, 63, 1587-1590.
82. Ankri, S., Stolarsky, T., Bracha, R., Padilla-Vac, F. and Mirelman, D. (1999) Antisense inhibition of expression of cysteine proteinases affects Entamoeba histolytica-induced formation of liver abscess in hamsters. Infection and Immunity, 67, 421-422.
83. Shenai, B.R., Lee, B.J., AlvarezHernandez, A., Chong, P.Y., Emal, C.D., Neitz, R.J., Roush, W.R. and Rosenthal, P. (2003) Structure-activity relationships for inhibition of cysteine protease activity and development of Plasmodium falciparum by peptidyl vinyl sulfones. Antimicrobial Agents and Chemotherapy, 47, 154-160.
84. Leung-Toung, R., Zhao, Y., Li, W., Tam, T.F., Karimian, K. and Spino, M. (2006) Thiol proteases: inhibitors and potential therapeutic targets. Current Medicinal Chemistry, 13, 547-581.
85. Abdulla, M.H., Lim, K.C., Sajid, M., McKerrow, J.H. and Caffrey, C.R. (2007) Schistosomiasis mansoni: novel chemotherapy using a cysteine protease inhibitor. PLoS Medicine, 4, e14.
86. Luft, B.J. and Remington, J.S. (1992) Toxoplasmic encephalitis in AIDS. Clinical Infectious Diseases, 15, 211-222.
87. McLeod, R., Boyer, K., Roizen, N., Stein, L., Swisher, C., Holfels, E., Hopkins, J. et al. (2000) The child with congenital toxoplasmosis. Current Clinical Topics in Infectious Diseases, 20, 189-208.
88. Gajria, B., Bahl, A., Brestelli, J., Dommer, J., Fischer, S., Gao, X., Heiges, M. et al. (2008) ToxoDB: an integrated Toxoplasma gondii database resource. Nucleic Acids Research, 36, D553-D556.
89. Que, X., Ngo, H., Lawton, J., Gray, M., Liu, Q., Engel, J., Brinen, L. et al. (2002) The cathepsin B of Toxoplasma gondii, toxopain-1, is critical for parasite invasion and rhoptry protein processing. The Journal of Biological Chemistry, 277, 25791-25797.
90. Shaw, M.K., Roos, D.S. and Tilney, L.G. (1998) Acidic compartments and rhoptry formation in Toxoplasma gondii. Parasitology, 117 (Pt 5), 435-443.
91. Que, X., Wunderlich, A., Joiner, K.A. and Reed, S.L. (2004) Toxopain-1 is critical for infection in a novel chicken embryo model of congenital toxoplasmosis. Infection and Immunity, 72, 2915-2921.
92. Barrett, A.J. (2004) Bioinformatics of proteases in the MEROPS database. Current Opinion in Drug Discovery & Development, 7, 334-341.
93. Que, X., Engel, J.C., Ferguson, D., Wunderlich, A., Tomavo, S. and Reed, S.L. (2007) Cathepsin Cs are key for the intracellular survival of the protozoan parasite, Toxoplasma gondii. The Journal of Biological Chemistry, 282, 4994-5003.
94. Turk, D., Janjic, V., Stern, I., Podobnik, M., Lamba, D., Dahl, S.W., Lauritzen, C. et al. (2001) Structure of human dipeptidyl peptidase I (cathepsin C): exclusion domain added to an endopeptidase framework creates the machine for activation of granular serine proteases. The EMBO Journal, 20, 6570-6582.
95. Miller, S.A., Binder, E.M., Blackman, M.J., Carruthers, V.B. and Kim, K. (2001) A conserved subtilisin-like protein TgSUB1 in microneme organelles of Toxoplasma gondii. The Journal of Biological Chemistry, 276, 45341-45348.
96. Miller, S.A., Thathy, V., Ajioka, J.W., Blackman, M.J. and Kim, K. (2003) TgSUB2 is a Toxoplasma gondii rhoptry organelle processing proteinase. Molecular Microbiology, 49, 883-894.
97. Binder, E.M. and Kim, K. (2004) Location, location, location: trafficking and function of secreted proteases of Toxoplasma and Plasmodium. Traffic (Copenhagen, Denmark), 5, 914-924.
98. Brossier, F., Jewett, T.J., Sibley, L.D. and Urban, S. (2005) A spatially localized rhomboid protease cleaves cell surface adhesins essential for invasion by Toxoplasma. Proceedings of the National Academy of Sciences of the United States of America, 102, 4146-4151.
99. Dowse, T.J. and Soldati, D. (2005) Rhomboid-like proteins in Apicomplexa: phylogeny and nomenclature. Trends in Parasitology, 21, 254-258.
100. LeChevalier, M.W., Norton, W.D. and Lee, R.G. (1991) Occurrence of Giardia and Cryptosporidium spp in surface water supplies. Applied and Environmental Microbiology, 57, 2610-2616.
101. Ong, C., Moorehead, W., Ross, A. and Isaac-Renton, J. (1996) Studies of Giardia spp. and Cryptosporidium spp. in two adjacent watersheds. Applied and Environmental Microbiology, 62, 2798-2805.
102. Fayer, R. and Ungar, B.L. (1986) Cryptosporidium spp. and cryptosporidiosis. Microbiological Reviews, 50, 458-483.
103. Awad-el-Kariem, F.M. (1996) Significant parity of different phenotypic and genotypic markers between human and animal strains of Cryptosporidium parvum. The Journal of Eukaryotic Microbiology, 43, 70.
104. Brasseur, P. (1997) Cryptosporidiosis: A major environmental risk. Journal of Eukaryotic Microbiology, 44, 67.
105. Georgi, J.R. and Georgi, M.E. (1990) Parasitology for Veterinarians, W.B. Saunders, Philadelphia.
106. Ungar, B.L.P. (1995) Cryptosporidium, Churchill Livingston, New York.
107. Moore, A.C., Herwaldt, B.L., Craun, G.F., Calderon, R.L., Highsmith, A.K. and Juranek, D.D. (1993) Surveillance for waterborne disease outbreaks-United States, 1991-1992. Morbidity and Mortality Weekly Report, CDC Surveillance Summary, 42, 1-22.
108. Checkley, W., Epstein, L.D., Gilman, R.H., Black, R.E., Cabrera, L. and Sterling, C.R. (1998) Effects of Cryptosporidium parvum infection in Peruvian children: growth faltering and subsequent catch-up growth. American Journal of Epidemiology, 148, 497-506.
109. Goodgame, R.W. (1996) Understanding intestinal spore-forming protozoa: cryptosporidia, microsporidia, isospora, and cyclospora. Annals of Internal Medicine, 124, 429-441.
110. Peterson, C. (1992) Cryptosporidiosis in patients infected with the human immunodeficiency virus. Clinical Infectious Diseases, 15, 903-909.
111. Bobin, J.Y. and Romestaing, P. (1998) Locoregional treatment of breast cancer: surgery and radiotherapy. La Revue du Praticien, 48, 53-59.
112. Le Moing, V., Bissuel, F., Costagliola, D., Eid, Z., Chapuis, F., Molina, J.M., Salmon-Ceron, D. et al. (1998) Decreased prevalence of intestinal cryptosporidiosis in HIV-infected patients concomitant to the widespread use of protease inhibitors. AIDS, 12, 1395-1397.
113. Forney, J.R., Yang, S., Du, C. and Healey, M.C. (1996) Efficacy of serine protease inhibitors against Cryptosporidium parvum infection in a bovine fallopian tube epithelial cell culture system. The Journal of Parasitology, 82, 638-640.
114. Forney, J.R., Yang, S. and Healey, M.C. (1997) Antagonistic effect of human alpha-1-antitrypsin on excystation of Cryptosporidium parvum oocysts. The Journal of Parasitology, 83, 771-774.
115. Forney, J.R., Yang, S. and Healey, M.C. (1996) Interaction of the human serine protease inhibitor alpha-1-antitrypsin with Cryptosporidium parvum. The Journal of Parasitology, 82, 496-502.
116. Forney, J.R., Yang, S. and Healey, M.C. (1997) Synergistic anticryptosporidial potential of the combination alpha-1-antitrypsin and paromomycin. Antimicrobial Agents and Chemotherapy, 41, 2006-2008.
117. Nesterenko, M.V., Tilley, M. and Upton, S.J. (1995) A metallo-dependent cysteine proteinase of Cryptosporidium parvum associated with the surface of sporozoites. Microbios, 83, 77-88.
118. Shaw, E. (1988) Peptidyl sulfonium salts. A new class of protease inhibitors. The Journal of Biological Chemistry, 263, 2768-2772.
119. Berriman, M., Ghedin, E., Hertz-Fowler, C., Blandin, G., Renauld, H., Bartholomeu, D.C., Lennard, N.J. et al. (2005) The genome of the African trypanosome Trypanosoma brucei. Science, 309, 416-422.
120. El-Sayed, N.M., Myler, P.J., Blandin, G., Berriman, M., Crabtree, J., Aggarwal, G., Caler, E. et al. (2005) Comparative Genomics of trypanosomatid parasitic protozoa, Science, 309, 404-409.
121. Mackey, Z.B., O'Brien, T.C., Greenbaum, D.C., Blank, R.B. and McKerrow, J.H. (2004) A cathepsin B-like protease is required for host protein degradation in Trypanosoma brucei. The Journal of Biological Chemistry, 279, 48426-48433.
122. Nikolskaia, O.V., Kim, Y.V., Kovbasnjuk, O., Kim, K.J. and Grab, D.J. (2006) Entry of Trypanosoma brucei gambiense into microvascular endothelial cells of the human blood-brain barrier. International Journal for Parasitology, 36, 513-519.
123. Coppens, I., Opperdoes, F.R., Courtoy, P.J. and Baudhuin, P. (1987) Receptor-mediated endocytosis in the bloodstream form of Trypanosoma brucei. The Journal of Protozoology, 34, 465-473.
124. Maier, A. and Steverding, D. (1996) Low affinity of Trypanosoma brucei transferrin receptor to apotransferrin at pH 5 explains the fate of the ligand during endocytosis. FEBS Letters, 396, 87-89.
125. Fujii, N., Mallari, J.P., Hansell, E.J., Mackey, Z., Doyle, P., Zhou, Y.M., Gut, J. et al. (2005) Discovery of potent thiosemicarbazone inhibitors of rhodesain and cruzain. Bioorganic & Medicinal Chemistry Letters, 15, 121-123.
126. Greenbaum, D.C., Mackey, Z., Hansell, E., Doyle, P., Gut, J., Caffrey, C.R., Lehrman, J. et al. (2004) Synthesis and structure-activity relationships of parasiticidal thiosemicarbazone cysteine protease inhibitors against Plasmodium falciparum, Trypanosoma brucei, and Trypanosoma cruzi. Journal of Medicinal Chemistry, 47, 3212-3219.
127. Mallari, J.P., Shelat, A.A., Obrien, T., Caffrey, C.R., Kosinski, A., Connelly, M., Harbut, M. et al. (2008) Development of potent purine-derived nitrile inhibitors of the trypanosomal protease TbcatB. Journal of Medicinal Chemistry, 51, 545-552.
128. Garcia-Sanmartin, J., Nagore, D., Garcia-Perez, A.L., Juste, R.A. and Hurtado, A. (2006) Molecular diagnosis of Theileria and Babesia species infecting cattle in Northern Spain using reverse line blot macroarrays. BMC Veterinary Research, 2, 16.
129. Boulter, N. and Hall, R. (1999) Immunity and vaccine development in the bovine theilerioses. Advances in Parasitology-Opportunistic Protozoa in Humans, 44, 41-97.
130. Irvin, A.D. and Morrison, I.W. (1987) Immunopathology, Immunology, and Immunoprophylaxis of Theileria Infections, CRC Press Inc., Baton Rouge.
131. Adamson, R., Logan, M., Kinnaird, J., Langsley, G. and Hall, R. (2000) Loss of matrix metalloproteinase 9 activity in Theileria annulata-attenuated cells is at the transcriptional level and is associated with differentially expressed AP-1 species. Molecular and Biochemical Parasitology, 106, 51-61.
132. Somerville, R.P., Adamson, R.E., Brown, C.G., Hall, F.R. et al. (1998) Metastasis of Theileria annulata macroschizont-infected cells in scid mice is mediated by matrix metalloproteinases. Parasitology, 116 (Pt 3), 223-228.
133. Pain, A., Renauld, H., Berriman, M., Murphy, L., Yeats, C.A., Weir, W., Kerhornou, A. et al. (2005) Genome of the host-cell transforming parasite Theileria annulata compared with T. parva. Science, 309, 131-133.
134. Gardner, M.J., Bishop, R., Shah, T., de Villiers, E.P., Carlton, J.M., Hall, N., Ren, Q. et al. (2005) Genome sequence of Theileria parva, a bovine pathogen that transforms lymphocytes. Science, 309, 134-137.
135. Rawlings, N.D., Morton, F.R., Kok, C.Y., Kong, J. and Barrett, A.J. (2008) MEROPS: the peptidase database. Nucleic Acids Research, 36, D320-D325.
136. Shiels, B., Langsley, G., Weir, W., Pain, A., McKellar, S. and Dobbelaere, D. (2006) Alteration of host cell phenotype by Theileria annulata and Theileria parva: mining for manipulators in the parasite genomes. International Journal for Parasitology, 36, 9-21.
137. Carlos, J.L., Paetzel, M., Brubaker, G., Karla, A., Ashwell, C.M., Lively, M.O., Cao, G. et al. (2000) The role of the membrane-spanning domain of type I signal peptidases in substrate cleavage site selection. The Journal of Biological Chemistry, 275, 38813-38822.
138. Paetzel, M., Dalbey, R.E. and Strynadka, N.C. (2000) The structure and mechanism ofbacterial type I signal peptidases. A novel antibiotic target. Pharmacology & Therapeutics, 87, 27-49.
139. Nomura, T. and Katunuma, N. (2005) Involvement of cathepsins in the invasion, metastasis and proliferation of cancer cells. The Journal of Medical Investigation, 52, 1-9.
140. Desjeux, P. (1996) Leishmaniasis. Public health aspects and control. Clinics in Dermatology, 14, 417-423.
141. Sundar, S. (2001) Drug resistance in Indian visceral leishmaniasis. Tropical Medicine & International Health, 6, 849-854.
142. Basselin, M., Coombs, G.H. and Barrett, M.P. (2000) Putrescine and spermidine transport in Leishmania. Molecular and Biochemical Parasitology, 109, 37-46.
143. Morty, R.E., Troeberg, L., Pike, R.N., Jones, R., Nickel, P., Lonsdale-Eccles, J.D. and Coetzer, T.H. (1998) A trypanosome oligopeptidase as a target for the trypanocidal agents pentamidine, diminazene and suramin. FEBS Letters, 433, 251-256.
144. Valdivieso, E., Dagger, F. and Rascon, A. (2007) Leishmania mexicana: identification and characterization of an aspartyl proteinase activity. Experimental Parasitology, 116, 77-82.
145. Silva-Lopez, R.E., Morgado-Diaz, J.A., Chavez, M.A. and Giovanni-De-Simone, S. (2007) Effects of serine protease inhibitors on viability and morphology of Leishmania (Leishmania) amazonensis promastigotes. Parasitology Research, 101, 1627-1635.
146. de Matos Guedes, H.L., Carneiro, M.P., Gomes, D.C., Rossi-Bergmanmn, B. and Giovanni de Simone, S. (2007) Oligopeptidase B from L. amazonensis: molecular cloning, gene expression analysis and molecular model. Parasitology Research, 101, 853-863.
147. Ambit, A., Fasel, N., Coombs, G.H. and Mottram, J.C. (2008) An essential role for the Leishmania major metacaspase in cell cycle progression. Cell Death and Differentiation, 15, 113-122.
148. Mottram, J.C., Souza, A.E., Hutchison, J.E., Carter, R., Frame, M.J. and Coombs, G.H. (1996) Evidence from disruption of the lmcpb gene array of Leishmania mexicana that cysteine proteinases are virulence factors. Proceedings of the National Academy of Sciences of the United States of America, 93, 6008-6013.
149. Mundodi, V., Kucknoor, A.S. and Gedamu, L. (2005) Role of Leishmania (Leishmania) chagasi amastigote cysteine protease in intracellular parasite survival: studies by gene disruption and antisense mRNA inhibition. BMC Molecular Biology, 6, 3.
150. Buxbaum, L.U., Denise, H., Coombs, G.H., Alexander, J., Mottram, J.C. and Scott, P. (2003) Cysteine protease B of Leishmania mexicana inhibits host Th1 responses and protective immunity. Journal of Immunology (Baltimore, Md: 1950), 171, 3711-3717.
151. Selzer, P.M., Chen, X., Chan, V.J., Cheng, M., Kenyon, G.L., Kuntz, I.D., Sakanari, J.A. et al. (1997) Leishmania major: molecular modeling of cysteine proteases and prediction of new nonpeptide inhibitors. Experimental Parasitology, 87, 212-221.
152. Selzer, P.M., Pingel, S., Hsieh, I., Ugele, B., Chan, V.J., Engel, J.C., Bogyo, M. et al. (1999) Cysteine protease inhibitors as chemotherapy: Lessons from a parasite target. Proceedings of the National Academy of Sciences of the United States of America, 96, 11015-11022.
153. Schlagenhauf, E., Etges, R. and Metcalf, P. (1998) The crystal structure of the Leishmania major surface proteinase leishmanolysin (gp63). Structure (London, England: 1993), 6, 1035-1046.
154. Brittingham, A., Morrison, C.J., McMaster, W.R., McGwire, B.S., Chang, K.P. and Mosser, D.M. (1995) Role of the Leishmania surface protease gp63 in complement fixation, cell adhesion, and resistance to complement-mediated lysis. Journal of Immunology (Baltimore, Md: 1950), 155, 3102-3111.
155. Joshi, P.B., Kelly, B.L., Kamhawi, S., Sacks, D.L. and McMaster, W.R. (2002) Targeted gene deletion in Leishmania major identifies leishmanolysin (GP63) as a virulence factor. Molecular and Biochemical Parasitology, 120, 33-40.
156. Kulkarni, M.M., McMaster, W.R., Kamysz, E., Kamysz, W., Engman, D.M. and McGwire, B.S. (2006) The major surface-metalloprotease of the parasitic protozoan, Leishmania, protects against antimicrobial peptide-induced apoptotic killing. Molecular Microbiology, 62, 1484-1497.
157. Corradin, S., Ransijn, A., Corradin, G., Bouvier, J., Delgado, M.B., Fernandez-Carneado, J., Mottram, J.C. et al. (2002) Novel peptide inhibitors of Leishmania gp63 based on the cleavage site of MARCKS (myristoylated alanine-rich C kinase substrate)-related protein. The Biochemical Journal, 367, 761-769.
158. Adam, R.D. (2001) Biology of giardia lamblia. Clinical Microbiology Reviews, 14, 447-475.
159. Hedges, S.B. (2002) The origin and evolution of model organisms. Nature Reviews. Genetics, 3, 838-849.
160. Touz, M.C., Lujan, H.D., Hayes, S.F. and Nash, T.E. (2003) Sorting of encystation-specific cysteine protease to lysosome-like peripheral vacuoles in Giardia lamblia requires a conserved tyrosine-based motif. The Journal of Biological Chemistry, 278, 6420-6426.
161. Ward, W., Alvarado, L., Rawlings, N.D., Engel, J.C., Franklin, C. and McKerrow, J.H. (1997) A primitive enzyme for a primitive cell: the protease required for excystation of Giardia. Cell, 89, 437-444.
162. DuBois, K.N., Abodeely, M., Sajid, M., Engel, J.C. and McKerrow, J.H. (2006) Giardia lamblia cysteine proteases. Parasitology Research, 99, 313-316.
163. Mottram, J.C. North, M., Sajid, M., Edit, Barrett, A.J., Rawlings, N.D. and Woessner, J.F. (1998) Trichomonad and Giardia cysteine endopeptidases, in: Handbook of Proteolytic Enzymes, Academic Press, San Diego, pp. 1170-1173.